BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 32577796)

  • 1. Functional impact of HIV-1 Tat on cells of the CNS and its role in HAND.
    Marino J; Maubert ME; Mele AR; Spector C; Wigdahl B; Nonnemacher MR
    Cell Mol Life Sci; 2020 Dec; 77(24):5079-5099. PubMed ID: 32577796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-Associated Neurotoxicity: The Interplay of Host and Viral Proteins.
    Jadhav S; Nema V
    Mediators Inflamm; 2021; 2021():1267041. PubMed ID: 34483726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and functional heterogeneity of CNS-derived tat alleles from patients with HIV-associated dementia.
    Cowley D; Gray LR; Wesselingh SL; Gorry PR; Churchill MJ
    J Neurovirol; 2011 Feb; 17(1):70-81. PubMed ID: 21165788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signatures of HIV-1 subtype B and C Tat proteins and their effects in the neuropathogenesis of HIV-associated neurocognitive impairments.
    Williams ME; Zulu SS; Stein DJ; Joska JA; Naudé PJW
    Neurobiol Dis; 2020 Mar; 136():104701. PubMed ID: 31837421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 subtype B Tat enhances NOTCH3 signaling in astrocytes to mediate oxidative stress, inflammatory response, and neuronal apoptosis.
    Gao L; Sun W; Zhang D; Shang Y; Li L; Tao W; Zhang L; Liu H
    J Neurovirol; 2023 Aug; 29(4):479-491. PubMed ID: 37358698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrocyte elevated gene-1 is a novel modulator of HIV-1-associated neuroinflammation via regulation of nuclear factor-κB signaling and excitatory amino acid transporter-2 repression.
    Vartak-Sharma N; Gelman BB; Joshi C; Borgamann K; Ghorpade A
    J Biol Chem; 2014 Jul; 289(28):19599-612. PubMed ID: 24855648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactive role of human immunodeficiency virus type 1 (HIV-1) clade-specific Tat protein and cocaine in blood-brain barrier dysfunction: implications for HIV-1-associated neurocognitive disorder.
    Gandhi N; Saiyed ZM; Napuri J; Samikkannu T; Reddy PV; Agudelo M; Khatavkar P; Saxena SK; Nair MP
    J Neurovirol; 2010 Jul; 16(4):294-305. PubMed ID: 20624003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for spermine oxidase as a mediator of reactive oxygen species production in HIV-Tat-induced neuronal toxicity.
    Capone C; Cervelli M; Angelucci E; Colasanti M; Macone A; Mariottini P; Persichini T
    Free Radic Biol Med; 2013 Oct; 63():99-107. PubMed ID: 23665428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel insights into role of miR-320a-VDAC1 axis in astrocyte-mediated neuronal damage in neuroAIDS.
    Fatima M; Prajapati B; Saleem K; Kumari R; Mohindar Singh Singal C; Seth P
    Glia; 2017 Feb; 65(2):250-263. PubMed ID: 27761954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles and functions of HIV-1 Tat protein in the CNS: an overview.
    Bagashev A; Sawaya BE
    Virol J; 2013 Dec; 10():358. PubMed ID: 24359561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic attributes of blood-derived subtype-C HIV-1 tat and env in India and neurocognitive function.
    Tilghman MW; Bhattacharya J; Deshpande S; Ghate M; Espitia S; Grant I; Marcotte TD; Smith D; Mehendale S
    J Med Virol; 2014 Jan; 86(1):88-96. PubMed ID: 24150902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clade C HIV-1 isolates circulating in Southern Africa exhibit a greater frequency of dicysteine motif-containing Tat variants than those in Southeast Asia and cause increased neurovirulence.
    Rao VR; Neogi U; Talboom JS; Padilla L; Rahman M; Fritz-French C; Gonzalez-Ramirez S; Verma A; Wood C; Ruprecht RM; Ranga U; Azim T; Joska J; Eugenin E; Shet A; Bimonte-Nelson H; Tyor WR; Prasad VR
    Retrovirology; 2013 Jun; 10():61. PubMed ID: 23758766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methamphetamine and HIV-1 Tat down regulate β-catenin signaling: implications for methampetamine abuse and HIV-1 co-morbidity.
    Sharma A; Hu XT; Napier TC; Al-Harthi L
    J Neuroimmune Pharmacol; 2011 Dec; 6(4):597-607. PubMed ID: 21744004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the role of ankyrin-rich membrane spanning protein in human immunodeficiency virus type-1 Tat-induced microglia activation.
    Singh VB; Wooten AK; Jackson JW; Maggirwar SB; Kiebala M
    J Neurovirol; 2015 Apr; 21(2):186-98. PubMed ID: 25636783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The multiple roles of p53 in the pathogenesis of HIV associated dementia.
    Garden GA; Morrison RS
    Biochem Biophys Res Commun; 2005 Jun; 331(3):799-809. PubMed ID: 15865935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Tat-mediated induction of CCL5 in astrocytes involves NF-κB, AP-1, C/EBPα and C/EBPγ transcription factors and JAK, PI3K/Akt and p38 MAPK signaling pathways.
    Nookala AR; Shah A; Noel RJ; Kumar A
    PLoS One; 2013; 8(11):e78855. PubMed ID: 24244375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anticancer drug sunitinib promotes autophagyand protects from neurotoxicity in an HIV-1 Tat model of neurodegeneration.
    Fields JA; Metcalf J; Overk C; Adame A; Spencer B; Wrasidlo W; Florio J; Rockenstein E; He JJ; Masliah E
    J Neurovirol; 2017 Apr; 23(2):290-303. PubMed ID: 28105557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent long-term effects of Tat in the rat hippocampal formation: a design-based stereological study.
    Fitting S; Booze RM; Hasselrot U; Mactutus CF
    Hippocampus; 2010 Apr; 20(4):469-80. PubMed ID: 19489004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory Role of Complement Proteins in the Neuropathology Associated with Opiate Abuse and HIV-1 Co-Morbidity.
    Mahajan SD; Aalinkeel R; Parikh NU; Jacob A; Cwiklinski K; Sandhu P; Le K; Loftus AW; Schwartz SA; Quigg RJ; Alexander JJ
    Immunol Invest; 2017 Nov; 46(8):816-832. PubMed ID: 29058550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-TAT protein upregulates expression of multidrug resistance protein 1 in the blood-brain barrier.
    Hayashi K; Pu H; Andras IE; Eum SY; Yamauchi A; Hennig B; Toborek M
    J Cereb Blood Flow Metab; 2006 Aug; 26(8):1052-65. PubMed ID: 16395283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.